Clinical Trial Update: Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study) [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating thrombelastography-guided antiplatelet therapy in acute coronary syndromes was terminated, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Thrombosis

Snippet

Sponsor: Indiana University | Conditions: Thrombosis, Coronary Artery Disease | Phase 4 | Status: TERMINATED | Results posted: 2018-04-26